Skip to content

King & Wood Mallesons Pulse

  • Topics
    • All Topics
    • Carbon markets
    • Competition & consumer
    • Consumer protection
    • ESG
    • Future energy
    • Hydrogen
    • Inhouse Counsel
    • International Arbitration
    • Intellectual Property
    • Technology
  • Jurisdictions
    • Australia
    • China
    • Hong Kong
    • Singapore
    • Global
  • Specialty Blogs
    • In Competition
    • International Arbitration
    • IP Whiteboard
  • Authors

King & Wood Mallesons Pulse

  • Topics
    • All Topics
    • Carbon markets
    • Competition & consumer
    • Consumer protection
    • ESG
    • Future energy
    • Hydrogen
    • Inhouse Counsel
    • International Arbitration
    • Intellectual Property
    • Technology
  • Jurisdictions
    • Australia
    • China
    • Hong Kong
    • Singapore
    • Global
  • Specialty Blogs
    • In Competition
    • International Arbitration
    • IP Whiteboard
  • Authors

FDA

United States FDA gets serious about biosimilars

United States FDA gets serious about biosimilars

5 September 2018
By Suzy Madar
The most significant advances in medical treatments are being made with biological products. 
Read on
The future is now: Gene therapy lands in the United States

The future is now: Gene therapy lands in the United States

5 October 2017
By James MacLeod
The United States Food and Drug Authority (FDA) has just given the green light to America’s first ever gene therapy treatment.
Read on
US Food and Drug Administration releases draft guidances about social media and online communications

US Food and Drug Administration releases draft guidances about social media and online communications

3 July 2014
By Samantha McHugh
FDA releases two draft guidances relating to the promotion of prescription drugs or medical devices online or on social media.
Read on

Speciality Blogs

  • In Competition
  • International Arbitration
  • IP Whiteboard

More From IP Whiteboard

  • IP Whiteboard

Trending Topics

  • Dispute resolution & litigation
  • Hong Kong
  • Litigation
  • Technology
View All Topics

Most Viewed

Bilateral relations for Australia & China enter a new chapter

Read More

ASIC flexes muscles in scam and phishing takedowns

Read More
King & Wood Mallesons
©2025 King & Wood Mallesons

Follow Us

  • LinkedIn
  • Facebook
  • Twitter
Subscribe to KWM Pulse
Terms of use & legal notices | Privacy statement
©2025 King & Wood Mallesons